Qingsu Cheng

Qingsu Cheng

  • Assistant Professor, Biomedical Engineering

Prior to joining UWM, Dr. Cheng did his postdoc training at Lawrence Berkeley National Lab and became a research scientist at University of Nevada Reno. In his Cancer Therapeutics, Microbiome, and Imaging Lab, he has contributed to developing quantitative assays for high content screening of organoid models. By using this model, he continued investigating organoid formation under the exposure of environmental factors. He also synthesized C60-nucleic acid probes (patent 10626469 issued by April of 2020) for identifying live foodborne microorganisms. Recently, he initiated development of breast cancer treatment by investigating organoid-fibroblast interactions.


  • PhD, Biomedical Engineering, University of South Carolina
  • MS, Biochemical Engineering, Sichuan University
  • BS, Bioengineering, Nanjing University of Technology

Research Interests

  • Bioimaging

  • Cancer Microenvironment

  • Nanotechnology

  • Microbiome


Google Scholar Link

Community Involvement

  • NASA HRP Review Panel 2023
  • Referee for Journal of Biomedical Materials Engineering Research Part A., Carbohydrate, Plant and soil, Ecotoxicology and Environmental Safety, MDPI Diagnostic and MDPI Cells
  • NIH Review Panel: ZRG1 OTC1-M(80), 2022
  • Co-Founder of RiboFlare, developing microbial probes for food industry
  • Member of American Institute of Chemical Engineers, Biomedical Engineering Society and IEEE